SEC Company Response from Rein Therapeutics, Inc. (RNTX) (CIK 0001420565) (RNTX) — Jul 11, 2019
Rein Therapeutics, Inc. (RNTX) (CIK 0001420565)
Date: July 11, 2019 · CIK: 0001420565 · Accession: 0001193125-19-192235
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-226650
Letter
AILERON THERAPEUTICS, INC.
490 Arsenal Way, Suite 210
Watertown, MA 02472
July 11, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Aileron Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-226650
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-226650), so that it may become effective at 4:00 p.m. Eastern time on July 15, 2019, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
AILERON THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP AILERON THERAPEUTICS, INC. 490 Arsenal Way, Suite 210 Watertown, MA 02472 July 11, 2019 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Aileron Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-226650 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-226650), so that it may become effective at 4:00 p.m. Eastern time on July 15, 2019, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, AILERON THERAPEUTICS, INC. By: /s/ Donald V. Dougherty Name: Donald V. Dougherty Title: Senior Vice President, Chief Financial Officer cc: Stuart M. Falber Wilmer Cutler Pickering Hale and Dorr LLP